TGFBR2 and neoplasm: For the Apc mutants, we isolated tumors at 36 weeks of age, when they had extensive adenosquamous HGPIN, and at 20–24 weeks from the Apc;Tgfbr2 mutants when they first showed adverse signs of tumor burden.